Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | RELA | Q04206 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.48 |
| ▸ | TUBB | P07437 | 1/20 | 0.48 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.48 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.48 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.48 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.48 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.48 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.48 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.48 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.48 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.48 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.48 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.48 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1130133 | 1.00 | MEN1 (0.55) | MEN1KMT2AALDH1A1GAARELA | |
| SCHEMBL3272348 | 0.86 | GAA (0.57) | MEN1KMT2AALDH1A1GAARELA | |
| SCHEMBL1643205 | 0.81 | ALDH1A1 (0.48) | MEN1KMT2AALDH1A1GAAL3MBTL1 | |
| SCHEMBL1643202 | 0.81 | ALDH1A1 (0.48) | MEN1KMT2AALDH1A1GAAL3MBTL1 | |
| SCHEMBL28610776 | 0.81 | ALDH1A1 (0.48) | MEN1KMT2AALDH1A1GAAL3MBTL1 | |
| SCHEMBL11803792 | 0.80 | ALDH1A1 (0.51) | MEN1KMT2AALDH1A1GAARELA | |
| SCHEMBL15095589 | 0.79 | ALDH1A1 (0.56) | MEN1KMT2AALDH1A1GAAL3MBTL1 | |
| SCHEMBL8773631 | 0.77 | LMNA (0.61) | MEN1KMT2AALDH1A1GAARELA | |
| SCHEMBL8773627 | 0.77 | LMNA (0.61) | MEN1KMT2AALDH1A1GAARELA | |
| SCHEMBL11675095 | 0.77 | ALDH1A1 (0.44) | MEN1KMT2AALDH1A1GAARELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158135-B2 | Imine based liquid crystals for the controlled release of bioactive materials | FIRMENICH SA (CH) | 2012-04-17 | — | — | US | disclosed |
| EP-2010231-B1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH & CIE (CH) | 2011-02-16 | — | — | EP | disclosed |
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2009-12-10 | — | — | US | disclosed |
| EP-2010231-A2 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | Firmenich S.A. (CH) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007113711-A2 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306196-A1 | IMINE BASED LIQUID CRYSTALS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | BCHE, ACHE, LIPE | MEN1 52/4885KMT2A 4535/4885ALDH1A1 3124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.